Update on Hybrid Conjugate-View SPECT Tumor Dosimetry and Response in ¹³¹I-Tositumomab Therapy of Previously Untreated Lymphoma Patients.

Autor: Koral, Kenneth F., Dewaraja, Yuni, Jia Li, Qiang Lin, Regan, Denise D., Zasadny, Kenneth R., Rommelfanger, Stephen G., Francis, Issac R., Kaminski, Mark S., Wahl, Richard L.

Publikováno v: Journal of Nuclear Medicine; Mar2003, Vol. 44 Issue 3, p457-464, 8p, 3 Charts, 2 Graphs

Metabolic Response of Non-Hodgkin's Lymphoma to ¹³¹I-Anti-B1 Radioimmunotherapy: Evaluation with FDG PET.

Autor: Torizuka, Tatsuo, Zasadny, Kenneth R., Kison, Paul V., Rommelfanger, Stephen G., Kaminski, Mark S., Wahl, Richard L.

Publikováno v: Journal of Nuclear Medicine; Jun2000, Vol. 41 Issue 6, p999-1005, 7p, 3 Black and White Photographs, 2 Charts, 3 Graphs

Attenuation characteristics of a new compensator material: Thermo-Shield for high energy electron and photon beams.

Autor: Paliwal, Bhudatt R., Rommelfanger, Stephen, Das, Rupak K.

Publikováno v: Medical Physics; 1998, Vol. 25 Issue 4, p484-487, 4p

Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients.

Autor: Koral KF; Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0028, USA. kenkoral@umich.edu, Dewaraja Y, Li J, Lin Q, Regan DD, Zasadny KR, Rommelfanger SG, Francis IR, Kaminski MS, Wahl RL

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2003 Mar; Vol. 44 (3), pp. 457-64.